FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Elan

Elan considers selling division

July 21, 2008 — 11:29am ET | By John Carroll
Tools

Ireland's Elan is considering selling its development and manufacturing division for around $1.5 billion, a move that would leave the company devoted to its bio-pharmaceuticals business. Report

Bookmark and Share
Get Your FREE FierceBiotech Email Newsletter:
Comments (1) | Post a comment
More stories about Elan  

Comments

By jan ronk | Posted 10:20pm | July 22, 2008

when is someone going to restore the old mysoline 250 mg. tablet formula? patients are reporting problems with the new formula. this medication worked. the new meds are not working. why fix what is not broken? or caused law suits and birth defects?

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.